Literature DB >> 8205459

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.

R Collins1, S MacMahon.   

Abstract

Most evidence about the effects of blood pressure on the risks of cardiovascular disease derives from two principal sources: prospective non-randomised observational studies of the associations between blood pressure and the incidence of stroke and of coronary heart disease, and randomised trials of antihypertensive drug therapy. The focus of the first part of this chapter concerns the evidence from observational studies, which--despite the possibility of confounding by other risk factors--may be more relevant to the eventual effects of prolonged blood pressure differences on stroke and coronary heart disease risk. The focus of the second part concerns the evidence from randomised trials of antihypertensive drug treatment, which are more relevant to assessing how rapidly, and to what extent, the epidemiologically expected reductions in stroke or in coronary heart disease are produced by suddenly lowering blood pressure in middle and old age.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8205459     DOI: 10.1093/oxfordjournals.bmb.a072892

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  82 in total

Review 1.  The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes.

Authors:  P King; I Peacock; R Donnelly
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 2.  Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role?

Authors:  F Dunne; M J Kendall; U Martin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?

Authors:  S Ramachandran; J M French; M P Vanderpump; P Croft; R H Neary
Journal:  BMJ       Date:  2000-03-11

4.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

Review 5.  Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Authors:  D J Sheridan; M P Kingsbury; N A Flores
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

Review 6.  Prospectively designed overviews of recent trials comparing antihypertensive regimens based on different drug classes.

Authors:  N Chapman; B Neal
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

7.  Cholesterol and coronary heart disease: screening and treatment.

Authors:  S Ebrahim; G D Smith; C McCabe; N Payne; M Pickin; T A Sheldon; F Lampe; F Sampson; S Ward; G Wannamthee
Journal:  Qual Health Care       Date:  1998-12

8.  The effect on ambulatory blood pressure of working under favourably and unfavourably perceived supervisors.

Authors:  N Wager; G Fieldman; T Hussey
Journal:  Occup Environ Med       Date:  2003-07       Impact factor: 4.402

9.  Ongoing trials: what should we expect after ALLHAT?

Authors:  Ji-Guang Wang; Jan A Staessen; Anthony M Heagerty
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

10.  Financial and health costs of uncontrolled blood pressure in the United Kingdom.

Authors:  Adam Lloyd; Claudia Schmieder; Nick Marchant
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.